OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Multiple strategies have been employed enhance antibody titer, including process parameter optimization, media optimization, and adoption of perfusion processes. Fine-tuning media composition pla